Ostomy drainage bags market size is poised to depict commendable growth through 2023-2032, owing to the rising prevalence of inflammatory bowel diseases. Stoma surgery is conducted as part of IBD treatment through the opening of the abdomen to divert urine or feces into bags attached to the opening.
According to research data from Crohn’s & Colitis UK, in 2022, 1 in 123 people have either ulcerative colitis or Crohn’s disease in the UK, amounting to nearly half a million people with IBD. This growing disease burden will proliferate the demand for ostomy-drainable pouches to permit bodily waste to pass through the stoma.
Ostomy refers to a surgical procedure that creates an opening or stoma in the abdomen, changing the way body waste exits. This procedure was designed to treat a range of digestive or urinary systems. It is also considered a life-saving procedure and can significantly improve the quality of life. Ostomies can either be permanent or temporary depending on the unique healthcare needs.
The ever-increasing elderly population is a prominent factor fostering the global ostomy drainage bags market trends over the estimated timeline. Based on the WHO, by 2050, geriatric people aged 60 years and above will double to reach 2.1 billion. Since aging is associated with the high burden of colorectal cancer and other diseases due to compromised immune systems, the demand for ostomy bags will rise. Furthermore, the escalating investment to create robust healthcare systems will also augment product demand over the forthcoming years.
Colostomy bags industry size is set to witness commendable growth through 2032, driven by the robust product applicability among patients of all ages and the growing incidence of Crohn’s disease. As per statistics from the National Library of Medicine, every 100 to 300 per 100,000 people are diagnosed with Crohn’s disease in North America and Europe. This disease prevalence is driving the demand for colostomy bag drainage systems, as they are typically recommended for patients experiencing problems with the colon. However, complications including excessive bleeding and allergic reactions to anesthesia may limit their usage to a certain extent.
With regard to end-use, the ostomy drainage bags Market from hospitals segment will account for a substantial market share over the forthcoming years, owing to the delivery of specialized care and the presence of trained healthcare professionals in such facilities. Several community hospitals also provide care services for a variety of cancers. These factors, alongside high diagnostic accuracy, will encourage patients to conduct stoma surgery in hospital settings and create lucrative growth opportunities for ostomy bag developers.
On the regional front, the North America ostomy drainage bags market share will expand considerably over 2023-2032, considering the escalating number of senior citizens prone to cancer and other chronic diseases. As per data from the U.S. Census Bureau, by 2030, there will be nearly 73.1 million older adults in the nation. Additionally, the growing incidence of digestive disorders will further bolster the production of ostomy disposal bags in America.
The competitive landscape of the ostomy drainage bags market comprises companies such as Welland Medical, Torbot Group, Salts Healthcare, Pelican Healthcare, Flexicare (Group) Limited, Convatec Group plc, Coloplast, B. Braun, Nu-Hope Laboratories, and ALCARE, among others. These companies are focusing on business expansions, innovative product launches, mergers, and acquisitions to expand their footprint in the global market.
Inflation is at a record high and is asserting a profound impact on the healthcare sector. As per a tracker from the Peterson Center and the Kaiser Family Foundation, in July 2022, medical care expenses rose by 4.8% as compared to a year earlier. These factors may limit cancer and other chronic disease treatments and assert a negative influence on ostomy drainage bag industry development to some extent over the foreseeable future.